Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical StudyMichèle Cavo, Michele Baccarani, Patrizia Tosi et al.|Journal of Clinical Oncology|2007Cited by 374
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaMichèle Cavo, Antonio Palumbo, Lucia Pantani et al.|Blood|2012Cited by 310
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapyMichèle Cavo, Michele Baccarani, Elena Zamagni et al.|Blood|2002Cited by 152
<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centresLivio Pagano, A. Del Favero, Luana Fianchi et al.|British Journal of Haematology|2002Cited by 149
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.Patrizia Tosi, Michèle Cavo, S Tura et al.|PubMed|2002Cited by 111